Search for: "ELI LILLY V TEVA PHARMA"
Results 41 - 60
of 105
Sort by Relevance
|
Sort by Date
10 Aug 2010, 8:44 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
4 Aug 2010, 12:21 am
Eli Lilly (Orange Book Blog) (Patently-O) (Gray on Claims) (Patent Docs) Gynazole-1 (Butoconazole) – US: Perrigo confirms filing for generic version of Gynazole-1 cream and announcement of patent infringement lawsuit by KV Pharma (SmartBrief) Hectorol (Doxercalciferol) – US: Patent infringement complaint following a Paragraph IV certification: Genzyme Corp. v. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Zometa (Zoledronic acid) – US: Teva and Novartis settle patent dispute over Zometa (Patent Docs) Zyprexa (Olanzapine) – Canada: Patent Act contains no reference to invalid selection patents: Eli Lilly v Novopharm (Patent Baristas) [read post]
7 Jul 2010, 5:14 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Jul 2010, 6:03 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Evista (Raloxifene) – US: Patent infringement complaint following a Paragraph IV certification: Eli Lilly & Company v. [read post]
27 Apr 2010, 10:58 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Apr 2010, 4:27 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
10 Feb 2010, 4:47 pm
Aurobindo Pharma Ltd. et al. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v… [read post]
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment: Wyeth… [read post]
6 Jan 2010, 3:32 am
Ipsen Pharma, S.A.S. et al. [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against… [read post]
16 Dec 2009, 3:39 am
Eli Lilly & Co. [read post]
9 Dec 2009, 3:59 pm
: Roche v Cipla (Spicy IP) India, intellectual property and biotechnology industry – to protect, or not to protect (Biotech Blog) Italy: SPCs, competition and refusal to supply – Italian Competition Authority’s responses to ‘refusal to deal’ questionnaire (The SPC Blog) US: Ariad v Lilly – amicus briefs by Regents of University of California et al and various companies (Patent Docs) (Patent Docs) US: Ariad v Lilly… [read post]
